Adv Powder Technol
And so it took the pharmaceutical industry quite a while to figure out how to make GLP-1 last longer so it's not broken down, how to give small amounts to start off with, how to slowly build up the dose, et cetera
Designed for diabetes, not weight loss The goal of the study was to find out how much weight loss and gastrointestinal side effects happened in adults who were overweight or had obesity and were taking tirzepatide or semaglutide, both of which are approved for type 2 diabetes, in a clinical setting
Semaglutide doses range from 0.25mg to 2.4mg, much lower than tirzepatide doses of 2.5mg to 15mg
When people talk about GLP-1 response changing after 40, they are usually referring to differences in how the body reacts to the same dose
PubMed, Giannetti, Matthew P., et al